Accelevir Diagnostics, LLC

855 N Wolfe Street Rangos Suite B
Baltimore, MD 21205

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.57MM
Active Awards 1 valued at $500K
First Award Date 06/27/16
Most Recent Award Date 09/15/17

Key Personnel

Last Name Name Awards Contact
LAIRD GREGORY MICHAEL LAIRD 7 Message

5 Awards Won

Phase 2 SBIR Active

Agency: National Science Foundation
Topic: BM
Budget: 09/15/17 - 08/31/19

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to enable and support the future development, approval, and clinical use of new therapeutics the cure HIV-1 infection. HIV-1 infection can be controlled by available antiretroviral therapy, but cannot be cured due to the persistence...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-101
Budget: 08/18/17 - 07/31/18

Project Summary/Abstract Human immunodeficiency virus type-1 (HIV-1) is a retrovirus that infects CD4+ T cells of the immune system. If left untreated, HIV-1 infected individuals will progress to AIDS and may ultimately die as a result. Combination antiretroviral therapy is extremely effective at stopping the replication of HIV-1 in infected in...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-101
Budget: 08/01/17 - 04/30/18

Project Summary/Abstract Human immunodeficiency virus type-1 (HIV-1) is a retrovirus that infects CD4+ T cells of the immune system. If left untreated, HIV-1 infected individuals will progress to AIDS and may ultimately die as a result. Combination antiretroviral therapy is extremely effective at stopping the replication of HIV-1 in infected in...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BM
Budget: 07/01/16 - 03/31/17

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to enable and support the development, approval, and clinical use of new therapeutics the cure HIV-1 infection. HIV-1 infection can be controlled by available antiretroviral therapy, but cannot be cured due to the persistence of the virus...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-101
Budget: 06/27/16 - 05/31/17

Project Summary/Abstract Human immunodeficiency virus type-1 (HIV-1) is a retrovirus that infects CD4+ T cells ofthe immune system. If left untreated, HIV-1 infected individuals will progress to AIDS and mayultimately die as a result. Combination antiretroviral therapy is extremely effective at stoppingthe replication of HIV-1 in infected indivi...